Search Results - "Enjeti, A. K."

Spontaneous major bleeding in acquired factor X deficiency secondary to AL‐amyloidosis by Enjeti, A. K., Walsh, M., Seldon, M.

“…Abnormal bleeding may be seen in up to a third of patients with amyloidosis. Factor X deficiency is the commonest acquired coagulopathy in amyloidosis. While…”
Get full text

Final analysis of Australasian Leukaemia & Lymphoma Group NHL29: A phase II study of ibrutinib, rituximab and mini‐CHOP in very elderly patients with newly diagnosed DLBCL by Verner, E., Johnston, A., Pati, N., Hawkes, E., Lee, H. P., Cochrane, T., Cheah, C. Y., Filshie, R., Purtill, D., Sia, H., Enjeti, A. K., Brown, C., Murphy, N., Curnow, J., Lee, K., Gandhi, M. K., Butcher, B. E., Trotman, J.

Get full text

The putative diabetic plasma marker, soluble CD36, is non‐cleaved, non‐soluble and entirely associated with microparticles by ALKHATATBEH, M. J., MHAIDAT, N. M., ENJETI, A. K., LINCZ, L. F., THORNE, R. F.

“…Background: CD36 is a widely expressed cell surface receptor that binds lipoproteins, and its function has been implicated in many complications of the…”
Get full text

The origin of circulating CD36 in type 2 diabetes by Alkhatatbeh, M J, Enjeti, A K, Acharya, S, Thorne, R F, Lincz, L F

“…Objective: Elevated plasma levels of the fatty acid transporter, CD36, have been shown to constitute a novel biomarker for type 2 diabetes mellitus (T2DM). We…”
Get full text

Bilateral breast lumps in a patient after sex mismatched allogeneic transplantation for aplastic anaemia by Enjeti, A K, Seldon, M, Braye, S

“…The diagnosis of acute leukaemia involving the breasts, soft tissue, and subsequently evident in the bone marrow required multiple diagnostic tissue sampling…”
Get full text

Bio-maleimide as a generic stain for detection and quantitation of microparticles by ENJETI, A. K., LINCZ, L., SELDON, M.

“…Summary Microparticles (MP) are small fragments of cytoplasm shed from a cell surface and their role in the pathophysiology of disease is being extensively…”
Get full text

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023 by Verner, E, Johnston, A, Pati, N, Hawkes, E, Lee, H P, Cochrane, T, Cheah, C Y, Filshie, R, Purtill, D, Sia, H, Enjeti, A K, Brown, C, Murphy, N, Curnow, J, Lee, K, Gandhi, M K, Butcher, B E, Trotman, J

Get full text

SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL by Verner, E.K., Johnston, A.J., Pati, N., Hawkes, E., Lee, H., Cochrane, T., Cheah, C.Y., Filshie, R., Purtill, D., Enjeti, A.K., Brown, C., Murphy, N., Curnow, J., Cake, S., Carlson, J., Butcher, B.E., Trotman, J.

Get full text

Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era by Lapuz, Carminia, Enjeti, Anoop K, O'Brien, Peter C, Capp, Anne L, Holliday, Elizabeth G, Gupta, Sanjiv A

“…This study evaluated relapse patterns and survival in advanced Hodgkin lymphoma (HL) patients treated with doxorubicin, bleomycin, vinblastine and dacarbazine…”
Get full text

Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis by Enjeti, A. K., Walsh, M., Seldon, M.

Get full text

Bilateral breast lumps in a patient after sex mismatched allogeneic transplantation for aplastic anaemia by Enjeti, A K, Seldon, M, Braye, S

Get full text